As the Chief Scientific Officer for Uprise Health’s Inflexxion, Dr. Green provides strategic direction for drug safety epidemiologic research design, development and enhancement of public health surveillance networks, generation and analysis of real-world evidence, and data dissemination activities for postmarket studies of prescription and nonprescription medications. She has also done extensive work partnering with government agencies and industry to combat the opioid crisis, including evaluating the effectiveness of interventions to reduce risk of overdose in adults and pediatrics. As an invited expert panelist, she has participated in FDA workshops to address methods for evaluating the effectiveness of abuse deterrent formulations of prescription opioid medications as well as ensuring safe opioid packaging, storage, and disposal. Dr. Green has over 20 years of research experience aimed to advance public health and patient safety, authoring or co-authoring 89 manuscripts in peer-reviewed journals.